title: miRNA-93 inhibits GLUT4 and is overexpressed in adipose tissue of polycystic ovary syndrome patients and women with insulin resistance.
abstract: Approximately 70% of women with polycystic ovary syndrome (PCOS) have intrinsic insulin resistance (IR) above and beyond that associated with body mass, including dysfunctional glucose metabolism in adipose tissue (AT). In AT, analysis of the IRS/PI3-K/AKT pathway signaling components identified only GLUT4 expression to be significantly lower in PCOS patients and in control subjects with IR. We examined the role of miRNAs, particularly in the regulation of GLUT4, the insulin-sensitive glucose transporter, in the AT of PCOS and matched control subjects. PCOS AT was determined to have a differentially expressed miRNA profile, including upregulated miR-93, -133, and -223. GLUT4 is a highly predicted target for miR-93, while miR-133 and miR-223 have been demonstrated to regulate GLUT4 expression in cardiomyocytes. Expression of miR-93 revealed a strong correlation between the homeostasis model assessment of IR in vivo values and GLUT4 and miR-93 but not miR-133 and -223 expression in human AT. Overexpression of miR-93 resulted in downregulation of GLUT4 gene expression in adipocytes through direct targeting of the GLUT4 3'UTR, while inhibition of miR-93 activity led to increased GLUT4 expression. These results point to a novel mechanism for regulating insulin-stimulated glucose uptake via miR-93 and demonstrate upregulated miR-93 expression in all PCOS, and in non-PCOS women with IR, possibly accounting for the IR of the syndrome. In contrast, miR-133 and miR-223 may have a different, although yet to be defined, role in the IR of PCOS.
authors.affiliation: Department of Obstetrics/Gynecology, Georgia Regents University, Augusta, Georgia, USA.
authors.forename: Yen-Hao
authors.initials: YH
authors.lastname: Chen
authors.forename: Saleh
authors.initials: S
authors.lastname: Heneidi
authors.forename: Jung-Min
authors.initials: JM
authors.lastname: Lee
authors.forename: Lawrence C
authors.initials: LC
authors.lastname: Layman
authors.forename: David W
authors.initials: DW
authors.lastname: Stepp
authors.forename: Gloria Mabel
authors.initials: GM
authors.lastname: Gamboa
authors.forename: Bo-Shiun
authors.initials: BS
authors.lastname: Chen
authors.forename: Gregorio
authors.initials: G
authors.lastname: Chazenbalk
authors.forename: Ricardo
authors.initials: R
authors.lastname: Azziz
mesh_terms: D017667:Adipocytes / Q000378:metabolism; D000273:Adipose Tissue / Q000378:metabolism*; D000328:Adult; D015536:Down-Regulation; D005260:Female; D051275:Glucose Transporter Type 4 / Q000235:genetics / Q000378:metabolism*; D006801:Humans; D007333:Insulin Resistance / Q000235:genetics*; D035683:MicroRNAs / Q000235:genetics / Q000378:metabolism*; D011085:Polycystic Ovary Syndrome / Q000235:genetics / Q000378:metabolism*; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism; D015398:Signal Transduction / Q000235:genetics
chemical_list: D051275:Glucose Transporter Type 4; C543350:MIRN93 microRNA, human; D035683:MicroRNAs; D012333:RNA, Messenger